关注
Bradley Stish
Bradley Stish
Senior Associate Consultant
在 mayo.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Improved metastasis-free and survival outcomes with early salvage radiotherapy in men with detectable prostate-specific antigen after prostatectomy for prostate cancer
BJ Stish, TM Pisansky, WS Harmsen, BJ Davis, KS Tzou, R Choo, ...
Journal of Clinical Oncology 34 (32), 3864-3871, 2016
2312016
The mutational landscape of metastatic castration-sensitive prostate cancer: the spectrum theory revisited
MP Deek, K Van der Eecken, R Phillips, NR Parikh, PI Velho, TL Lotan, ...
European urology 80 (5), 632-640, 2021
802021
Association of presalvage radiotherapy PSA levels after prostatectomy with outcomes of long-term antiandrogen therapy in men with prostate cancer
RT Dess, Y Sun, WC Jackson, NK Jairath, AU Kishan, DG Wallington, ...
JAMA oncology 6 (5), 735-743, 2020
752020
Development and validation of a clinical prognostic stage group system for nonmetastatic prostate cancer using disease-specific mortality results from the international staging …
RT Dess, K Suresh, MJ Zelefsky, SJ Freedland, BA Mahal, ...
JAMA oncology 6 (12), 1912-1920, 2020
652020
Metastasis-directed therapy prolongs efficacy of systemic therapy and improves clinical outcomes in oligoprogressive castration-resistant prostate cancer
MP Deek, K Taparra, R Phillips, PI Velho, RW Gao, C Deville, DY Song, ...
European urology oncology 4 (3), 447-455, 2021
632021
Increasing anticarcinoma activity of an anti-erbB2 recombinant immunotoxin by the addition of an anti-EpCAM sFv
BJ Stish, H Chen, Y Shu, A Panoskaltsis-Mortari, DA Vallera
Clinical cancer research 13 (10), 3058-3067, 2007
542007
Low dose rate prostate brachytherapy
BJ Stish, BJ Davis, LA Mynderse, RH McLaren, CL Deufel, R Choo
Translational andrology and urology 7 (3), 341, 2018
502018
A novel reduced immunogenicity bispecific targeted toxin simultaneously recognizing human epidermal growth factor and interleukin-4 receptors in a mouse model of metastatic …
S Oh, BJ Stish, D Sachdev, H Chen, AZ Dudek, DA Vallera
Clinical Cancer Research 15 (19), 6137-6147, 2009
442009
Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?
O Saifi, WG Breen, SC Lester, WG Rule, B Stish, A Rosenthal, J Munoz, ...
Radiotherapy and Oncology 166, 171-179, 2022
392022
Anti-glioblastoma effect of a recombinant bispecific cytotoxin cotargeting human IL-13 and EGF receptors in a mouse xenograft model
BJ Stish, S Oh, DA Vallera
Journal of neuro-oncology 87, 51-61, 2008
392008
Stereotactic body radiation therapy for nonspine bone metastases: international practice patterns to guide treatment planning
TK Nguyen, A Sahgal, R Dagan, W Eppinga, M Guckenberger, JH Kim, ...
Practical radiation oncology 10 (6), e452-e460, 2020
362020
Reirradiation for locoregional recurrent breast cancer
S Fattahi, SK Ahmed, SS Park, IA Petersen, DA Shumway, BJ Stish, ...
Advances in Radiation Oncology 6 (1), 100640, 2021
352021
Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity
BJ Stish, S Oh, H Chen, AZ Dudek, RA Kratzke, DA Vallera
British journal of cancer 101 (7), 1114-1123, 2009
332009
A bispecific recombinant cytotoxin (DTEGF13) targeting human interleukin-13 and epidermal growth factor receptors in a mouse xenograft model of prostate cancer
BJ Stish, H Chen, Y Shu, A Panoskaltsis-Mortari, DA Vallera
Clinical cancer research 13 (21), 6486-6493, 2007
332007
Patterns of recurrence after postprostatectomy fossa radiation therapy identified by C-11 choline positron emission tomography/computed tomography
WP Parker, JD Evans, BJ Stish, SS Park, K Olivier, R Choo, MA Nathan, ...
International Journal of Radiation Oncology* Biology* Physics 97 (3), 526-535, 2017
312017
Patient‐reported functional and quality of life outcomes in a large cohort of long‐term survivors of Ewing sarcoma
BJ Stish, SK Ahmed, PS Rose, CA Arndt, NN Laack
Pediatric blood & cancer 62 (12), 2189-2196, 2015
302015
Long-term outcomes and patterns of failure after surgical resection of small-cell lung cancer
BJ Stish, CL Hallemeier, KR Olivier, WS Harmsen, MS Allen, YI Garces
Clinical lung cancer 16 (5), e67-e73, 2015
282015
Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model
DA Vallera, BJ Stish, Y Shu, H Chen, A Saluja, DJ Buchsbaum, ...
Gut 57 (5), 634-641, 2008
282008
Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate …
H Zhang, JJ Orme, F Abraha, BJ Stish, VJ Lowe, F Lucien, EJ Tryggestad, ...
Clinical Cancer Research 27 (23), 6376-6383, 2021
262021
Permanent prostate brachytherapy monotherapy with I-125 for low-and intermediate-risk prostate cancer: Outcomes in 974 patients
DM Routman, RK Funk, BJ Stish, LA Mynderse, TM Wilson, R McLaren, ...
Brachytherapy 18 (1), 1-7, 2019
262019
系统目前无法执行此操作,请稍后再试。
文章 1–20